--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
US Stock MarketDetailed Quotes
CRDL Cardiol Therapeutics
- 2.4100
- -0.0800-3.21%
Close Jun 7 16:00 ET
- 2.4500
- +0.0400+1.66%
Post 18:33 ET
166.29MMarket Cap-7005P/E (TTM)
2.5300High2.3202Low410.04KVolume2.5300Open2.4900Pre Close984.55KTurnover0.62%Turnover RatioLossP/E (Static)69.00MShares2.810052wk High11.31P/B158.87MFloat Cap0.661052wk Low--Dividend TTM65.92MShs Float4.9600Historical High--Div YieldTTM8.43%Amplitude0.4500Historical Low2.4010Avg Price1Lot Size
Cardiol Therapeutics Key Stats
Cardiol Therapeutics Earnings Date
Currency: CAD
Period
Q1 FY2024 Earnings
--
Revenue(YoY)
0.00
0.00%EPS(YoY)
-0.14
-27.27%Analyst Rating
May 31, 2024
Cardiol Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CAD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Cardiol Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg